Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Huasu Pharmaceutical Co., Ltd. is a prominent Chinese pharmaceutical manufacturer based in Weihai, Shandong Province, serving as the primary production and research hub for the Huasu Pharmaceutical group. The company specializes in the development and large-scale manufacturing of chemical drug formulations and active pharmaceutical ingredients (APIs), with a core focus on cardiovascular, endocrine, and oral health therapeutic areas. Its commercial portfolio features well-recognized brands such as Yuanshu (Felodipine sustained-release tablets) and the flagship Huasu (Cydiodine) buccal tablets for oral infections. Operating under strict GMP standards, Shandong Huasu is integrated into the broader Zhongguancun Science-Tech Development network, leveraging advanced drug delivery technologies to maintain a strong market presence in China's chronic disease sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shandong Huasu Pharmaceutical.